Events by British Nuclear Medicine Society

BNMS Tech-Connect: Innovations in Scanning is a unique event specifically tailored for the technologists and radiographers who are the backbone of nuclear medicine departments. Recognizing that technology moves faster than textbooks, this Nottingham-based gathering focuses on the practical, "on-the-ground" innovations that improve patient experience and image acquisition. The event combines technical skill-building with high-level networking, allowing professionals from across the UK to share workflow efficiencies. The program highlights the transition to digital scanning environments. With many departments upgrading their hardware, there is a significant learning curve associated with new interface designs and motion-correction software. Expert technologists will lead sessions on "Optimizing the Pediatric Scan," focusing on immobilization techniques and dose reduction strategies that maintain diagnostic quality while ensuring the comfort of young patients. Another key theme is the management of the "Difficult Scan," addressing morbidly obese patients or those with severe claustrophobia, providing ergonomic tips and communication strategies. Innovation isn't just about the machines; it’s about the people. The "Tech-Connect" element of the event includes structured networking sessions where attendees can discuss career progression, the transition into Advanced Practitioner roles, and the evolving scope of practice in the UK. Manufacturers will also be on-site with "Sim-Suites," allowing participants to test-drive the latest software updates in a low-pressure environment. By focusing on the intersection of patient care and technical excellence, this event empowers the workforce to return to their hospitals with renewed confidence and a fresh perspective on departmental workflow.

The BNMS Oncology & Theranostics Symposium represents the cutting edge of modern medicine: the integration of diagnostics and therapeutics into a single, cohesive patient journey. This two-day conference in Nottingham focuses on the "See it, Treat it" philosophy that is revolutionizing the management of prostate cancer and neuroendocrine tumors. As theranostic centers expand across the UK, this event provides the necessary framework for clinicians to establish and scale their own programs. The symposium kicks off with a series of keynote addresses from international pioneers in Lutetium-177 PSMA therapy. These sessions cover patient selection criteria, dosimetry calculations, and the management of side effects. A significant portion of the first day is dedicated to the infrastructure requirements of a theranostics suite, including radiation protection for therapy rooms and the specialized nursing care required for patients undergoing radionuclide therapy. On day two, the focus shifts to the future of oncology. This includes the exploration of "The Next Wave" of theranostic pairs, such as Terbium isotopes and FAP-targeted ligands. There is also a dedicated session on the role of Artificial Intelligence in predictive dosimetry, showcasing how AI can help tailor the administered dose to the individual's unique tumor biology. The event concludes with a multidisciplinary panel involving oncologists, surgeons, and nuclear medicine physicians, emphasizing the importance of the "Theranostics Board" in decision-making. This symposium is essential for any professional looking to be at the forefront of the precision medicine revolution in the UK.

The BNMS Radiopharmacy Forum: Nottingham Seminar is a dedicated one-day event focusing on the rigorous standards and innovative breakthroughs in the production of radiopharmaceuticals. In the current regulatory climate, maintaining compliance with Good Manufacturing Practice (GMP) while integrating new isotopes into the clinical pipeline is a significant challenge for pharmacy departments across the UK. This seminar serves as a critical update for those working on the "front line" of isotope preparation. The morning sessions are dedicated to regulatory updates, featuring guest speakers from the MHRA and seasoned radiopharmacists who have successfully navigated recent inspections. Discussion topics include the implementation of automated synthesis modules and the transition from manual dispensing to robotic systems to minimize radiation exposure to staff. As the industry moves toward more centralized production models, the seminar explores the logistics of "hub and spoke" distribution and the stability of short-lived isotopes during transport. The afternoon transitions into a research-heavy focus, highlighting local Nottingham-based research into alpha-emitting isotopes. The potential of Actinium-225 and Lead-212 for targeted alpha therapy is a major highlight, with experts discussing the chemical challenges of stable chelation. Attendees will also participate in a roundtable discussion regarding the global supply chain issues affecting Molybdenum-99 and how UK centers can build resilience through domestic production initiatives. This seminar is more than just a series of lectures; it is a collaborative platform for radiopharmacists to share "lessons learned" and refine the protocols that ensure patient safety and product efficacy.

The BNMS Nottingham Molecular Imaging Workshop is a premier educational gathering designed to bridge the gap between theoretical radiopharmaceutical research and clinical application. Set against the backdrop of Nottingham’s thriving life sciences hub, this two-day intensive workshop focuses on the latest advancements in PET/CT and SPECT imaging protocols. As nuclear medicine evolves toward more personalized treatment pathways, the need for standardized imaging techniques has never been greater. The program begins with a deep dive into the physics of new detector technologies, exploring how digital PET systems are redefining sensitivity and spatial resolution. Participants will engage in hands-on data analysis sessions, learning to navigate complex quantification software that is becoming standard in modern oncology and neurology departments. The workshop also prioritizes the role of the multi-disciplinary team, emphasizing how technologists, physicists, and physicians must collaborate to ensure diagnostic accuracy. Beyond the technical lectures, the event features "Breakout Clinical Circles" where real-world case studies are dissected. These sessions allow attendees to troubleshoot common imaging artifacts and discuss the nuances of tracer kinetic modeling. The second day shifts focus toward emerging tracers beyond F-18 FDG, looking at the rise of Gallium-68 and Copper-64 labeled compounds in routine practice. By attending, delegates will gain not only continuing professional development credits but also a practical toolkit to improve patient throughput and image quality in their home institutions. This workshop is a vital stepping stone for those looking to master the complexities of modern molecular imaging in a supportive, expert-led environment.

The British Nuclear Medicine Society (BNMS) is proud to present its Annual Spring Meeting 2026, a landmark event marking the 60th anniversary of the society’s founding in 1966. This three-day conference serves as the premier independent forum in the United Kingdom dedicated to the advancement of nuclear medicine. It brings together a diverse community of healthcare professionals, including clinicians, clinical scientists, radiopharmacists, technologists, and nurses, to explore the latest innovations in clinical practice, education, and research. The 2026 program is designed to address the rapidly evolving landscape of molecular imaging and therapy. Attendees will engage with a comprehensive scientific program featuring proffered papers, poster presentations, and keynote lectures from world-renowned experts. Highlighting the anniversary, the event will feature a celebratory Plenary Lecture and the prestigious Annual Lecture delivered by Professor Stefano Fanti. Key clinical and technical themes include updates on Molecular Radiotherapy (MRT), PET/CT fundamentals, and the integration of artificial intelligence in image reporting. Beyond the lecture halls, the meeting hosts a large-scale commercial exhibition where industry leaders showcase the newest diagnostic equipment, radiopharmaceuticals, and software solutions. Education remains a core pillar of the BNMS mission. The 2026 meeting offers specialized training workshops focusing on MRT dosimetry and VARSKIN, alongside sessions on Myocardial Perfusion Imaging. The event is accredited for 16 CPD credits by the Royal College of Radiologists, ensuring that practitioners can meet their professional development requirements while gaining insights into workforce challenges and person-centered care. Networking is a vital component of the BNMS experience. The 2026 schedule includes a dedicated Members’ Reception, the President’s Reception, and the 60th Anniversary Awards Dinner and After Party. These social gatherings provide a unique opportunity for junior trainees and seasoned professionals to connect, collaborate, and celebrate the milestones of the nuclear medicine community. Whether you are looking to present original research or stay informed on regulatory updates, this meeting is the definitive event for the UK nuclear medicine sector.